Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors

By analysis of skin tumors from F1 hybrid mice we demonstrated that the genetic events that occur during tumor progression depend on the type of chemical carcinogenesis protocol used to induce tumor growth. More than 95% of tumors induced by initiation with 7, 12‐dimethylbenz[a]anthracene (DMBA) and promotion with 12‐O‐tetradecanoyl‐phorbol‐13‐acetate (TPA) exhibited mutations in Ha‐ras and trisomy of chromosome 7. Carcinomas induced with multiple DMBA treatments had a lower frequency of alterations on chromosome 7 (50%), but only in tumors with Ha‐ras mutations, and had a much wider spectrum of alterations, including trisomy, mitotic recombination, deletion, and gene duplication. Carcinomas induced with multiple N‐methyl‐N‐nitro‐N‐nitrosoguanidine treatments only rarely exhibited alterations on chromosome 7 (8%), even if they contained mutant Ha‐ras. More frequent numerical alterations of chromosome 11 were also seen in TPA‐promoted tumors (23%) than in tumors induced by multiple carcinogen treatments (8%). These results show that postinitiation events are nonrandom and fit a model in which promoting agents induce numerical chromosomal alterations but in which mutagens cause more directed mutational events. ©1994 Wiley‐Liss, Inc.

[1]  A. Balmain,et al.  Allelotype analysis of mouse skin tumors using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7, and 11. , 1993, Cancer research.

[2]  A. Ziegler,et al.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Balmain,et al.  A revised map position for the Ha‐ras gene on mouse chromosome 7: Implications for analysis of genetic alterations in rodent tumors , 1993, Molecular carcinogenesis.

[4]  E S Lander,et al.  A genetic map of the mouse suitable for typing intraspecific crosses. , 1992, Genetics.

[5]  I. Weinstein.  Toxicity, cell proliferation, and carcinogenesis , 1992, Molecular carcinogenesis.

[6]  A. Balmain,et al.  Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. , 1991, Oncogene.

[7]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Cavenee,et al.  Loss of constitutional heterozygosity in human cancer. , 1991, Annual review of genetics.

[9]  R. Tennant,et al.  Evidence that toxic injury is not always associated with induction of chemical carcinogenesis , 1991, Molecular carcinogenesis.

[10]  C. Conti,et al.  Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Ames,et al.  Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.

[12]  J. Love,et al.  Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. , 1990, Nucleic acids research.

[13]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[14]  A. Balmain,et al.  Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.

[15]  A. Balmain,et al.  Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Fusenig,et al.  Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion ('stage I of tumor promotion') in vivo. , 1989, Carcinogenesis.

[17]  L. Loeb,et al.  Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Mitelman,et al.  Primary chromosome abnormalities in human neoplasia. , 1989, Advances in cancer research.

[19]  T. Slaga,et al.  Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions , 1989, Molecular carcinogenesis.

[20]  E. Wynder,et al.  Effect of low-fat, high-carbohydrate, high-fiber diet on fecal bile acids and neutral sterols. , 1988, Preventive medicine.

[21]  N. Fusenig,et al.  Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: correlation with the convertogenic activity of TPA in multistage skin carcinogenesis. , 1988, Carcinogenesis.

[22]  A. Balmain,et al.  Oncogene activation in chemical carcinogenesis. , 1988, Advances in cancer research.

[23]  S. Yuspa,et al.  Chemical carcinogenesis: from animal models to molecular models in one decade. , 1988, Advances in cancer research.

[24]  A. Pellicer,et al.  Mutational activation of oncogenes in animal model systems of carcinogenesis. , 1987, Mutation research.

[25]  A. Balmain,et al.  Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis , 1986, Nature.

[26]  P. Fialkow,et al.  Papillomas induced by initiation–promotion differ from those induced by carcinogen alone , 1983, Nature.

[27]  R. Tarone,et al.  Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters , 1983, Nature.

[28]  A. Balmain,et al.  Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene , 1983, Nature.

[29]  N. Fusenig,et al.  Tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate enhances sister chromatid exchanges and numerical and structural chromosome aberrations in primary mouse epidermal cell cultures. , 1982, Cancer letters.

[30]  F. Marks,et al.  Skin tumor promotion by phorbol esters is a two-stage process. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Slaga,et al.  Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Boutwell,et al.  The function and mechanism of promoters of carcinogenesis. , 1974, CRC critical reviews in toxicology.